In this atopic dermatitis study, there are two treatment groups. You may receive the injectable study treatment drug or a placebo. Participants will not know in which group they have been placed. A placebo contains no active treatment and is used to ensure that the changes you report are not due to chance. Often called a “dummy” injection, an injectable placebo usually contains a harmless substance like saline solution (salt water).
All participants are helping medical scientists gain additional knowledge of atopic dermatitis treatment and helping others who suffer from this disease.
The goal is to help reduce inflammation, which could lead to fewer or milder symptoms of atopic dermatitis. This study treatment is investigational and has not yet been approved by the United States Food and Drug Administration (FDA) for the treatment of patients with atopic dermatitis. It is not currently available for purchase in any country.
All clinical research studies are monitored closely to ensure patient safety.
While enrolled in the study, participants will be under the care of a research team including study doctors, study nurses, and other research staff. Patients who are considering participation should consult with their doctors before enrolling in a research study.
*For additional eligibility criteria of the clinical trial, please visit: clinicaltrials.gov
We do not sell data to third parties. Data you submit is handled according to our Privacy Policy and web site use agreements.
To control data you have already submitted, or to log a do not sell data request, make a data request here.
To control data you have already submitted, make a data request here.
Data you submit is handled according to our Privacy Policy and web site user agreements.
